Immunohistochemistry was performed using antibodies against Aβ, tau and microglia markers in TREM2<sup>+</sup> cases, with and without AD, which were compared to sporadic TREM2<sup>-</sup> AD, familial AD and neurologically normal control cases. Here, MAPT is linked to Alzheimer disease.